Skip to content
IvaCaterina’s Waymakers

One gene, two inheritance patterns: a review of HSP

Some HSP genes can be passed on both dominantly and recessively. A 2026 review gathers the evidence, including for SPAST, the SPG4 gene, and explains why it matters for genetic counselling.

Author
Echipa editorialăThe association
Category
Science explained
Published
2 min read
Illustration: a DNA helix that turns into nerve fibres.

AI-generated illustrative image. It does not depict real people, patients or partners.

A plain-language summary of a published scientific study. It is educational and does not replace medical advice.

The study: Ravanbod M et al., Reviews in the Neurosciences, published online 22 October 2026. A literature review. Only the abstract is freely available.

What the researchers studied

Everyone has two copies of each gene, one from each parent. In a dominant condition, one altered copy is enough for the disease to appear; in a recessive one, both copies must be altered. SPG4 is classically autosomal dominant: each child of a person with SPG4 has a 50% chance of inheriting the variant.

HSP genes have traditionally been sorted by a single mode of inheritance. The authors systematically reviewed studies published up to June 2026 to see which genes can cause disease both ways.

What they found

  • Six genes are confirmed as having dual inheritance: ALDH18A1, ERLIN2, KIF1A, REEP2, UCHL1 and SPTSSA.
  • For five more genes regarded as dominant, there is evidence that also supports a recessive form: ATL1, SPAST, RTN2, BSCL2 and SPTAN1.
  • When both copies of a gene were altered, the disease generally started earlier and was more severe, but the link between variant and symptoms varied a lot from gene to gene.

What it means for families

The authors recommend that doctors look for variants on both copies of a gene even in genes regarded as "dominant only", especially in people with early onset or an unusually severe form. This can change the estimated risk for other children in the family, so genetic test results are worth discussing with a clinical geneticist.

What the study does not tell us yet

This is a review of cases already published, not a study of new patients. For SPAST, the evidence for a recessive form is described as "supporting", not established. For most families with SPG4, the classic dominant inheritance rule still applies.

References

  1. 1.

    Ravanbod M, Ghermezcheshmeh F, Rohani M, Alavi A (2026). Double trouble in hereditary spastic paraplegia: revisiting the classical inheritance model. Reviews in the Neurosciences (published online 22 October 2026).

    PMID 42905489Last verified: 7 November 2026

    HSP genes that can be inherited both dominantly and recessively, including evidence for SPAST.

  2. 2.

    Parodi L, Rydning SL, Tallaksen C, Durr A (2019). Spastic Paraplegia 4. GeneReviews®, University of Washington, Seattle (posted 2003; updated 13 June 2019).

    PMID 20301339Last verified: 6 November 2026

    The core clinical reference for SPG4: frequency, onset, symptoms, inheritance, diagnosis and symptomatic care.

Further sources

Share this article

All news
Illustration: a parent and a young child, seen from behind, reading a picture book on a sofa; small forearm crutches lean against the sofa.

Science explained

SPG4 in children: what parents need to know

SPG4 can begin in childhood. What is known about onset, diagnosis, care today, inheritance and research, explained for parents, with medical sources.

Illustration: two people, seen from behind, walking along a canal in autumn; one of them uses forearm crutches.

Science explained

What is SPG4? A guide for families

What an SPG4 diagnosis means, how it shows itself, how it is inherited, how it is confirmed and what can be done for symptoms today. In plain language, with medical sources.

Conceptual illustration: a teal six-part protein ring sitting on a pale-blue microtubule.

Science explained

SPG4 and SPG50: why they are different diseases

The Melpida gene therapy for SPG50 has given many families hope. We explain what it showed, why SPG4 is a different disease and what can realistically be learnt from it.